0 0 0 0 0 0 0 0
Sign Up Today X
Thanks for submitting the form.
Stockreport

2 Biotech Stocks to Buy as Coronavirus Fears Tank the Market [The Motley Fool]

Vertex Pharmaceuticals Incorporated (VRTX)  More Company Research Source: The Motley Fool
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
Last week, the stock market experienced its worst week since the financial crash of 008 But the worst thing investors can do at this point is panic. There are lots of companies with long-term prospects that will remain intact despite the recent developments surrounding COVID-9. In particular, here are two biotech stocks Vertex Pharmaceuticals ( NASDAQ:VRTX Global Blood Therapeutics NASDAQ:GBT The leader in the cystic fibrosis market The best reason to buy shares of Vertex Pharmaceuticals is the company's monopoly on the market for treatments for cystic fibrosis (CF). This rare genetic condition causes damage to the lungs and the digestive system, often shortening the patient's lifespan. Just 0 years ago, there were no treatments that addressed the underlying causes of CF approved by the U.S. Food and Drug Administration (FDA), but Vertex had several of its drugs aimed directly at the underlying causes of CF approved over the previous decade. The company's most recent approval is parti [Read more]
IMPACT SNAPSHOT EVENT TIME: VRTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
VRTX alerts
from News Quantified
VRTX
NEWS
VRTX
Earnings
VRTX
Analyst Actions
VRTX
SEC Filings
Stockreport

2 Biotech Stocks to Buy as Coronavirus Fears Tank the Market [The Motley Fool]

Vertex Pharmaceuticals Incorporated  (VRTX) 
More Company Research Source: The Motley Fool
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
Last week, the stock market experienced its worst week since the financial crash of 008 But the worst thing investors can do at this point is panic. There are lots of companies with long-term prospects that will remain intact despite the recent developments surrounding COVID-9. In particular, here are two biotech stocks Vertex Pharmaceuticals ( NASDAQ:VRTX Global Blood Therapeutics NASDAQ:GBT The leader in the cystic fibrosis market The best reason to buy shares of Vertex Pharmaceuticals is the company's monopoly on the market for treatments for cystic fibrosis (CF). This rare genetic condition causes damage to the lungs and the digestive system, often shortening the patient's lifespan. Just 0 years ago, there were no treatments that addressed the underlying causes of CF approved by the U.S. Food and Drug Administration (FDA), but Vertex had several of its drugs aimed directly at the underlying causes of CF approved over the previous decade. The company's most recent approval is parti [Read more]
IMPACT SNAPSHOT
EVENT TIME:
VRTX
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS